Published Date: 13 Mar 2023
OSA itself predicted the incidence of MACCE in non-obese patients.
Read Full News1.
Exercise can counter detrimental effects of cancer treatment, review suggests
2.
Treatment of Smoldering Myeloma Cuts Progression Rate in Half
3.
In Resectable Lung Cancer, Perioperative Nivolumab Increases EFS.
4.
Is global cancer care losing its human touch?
5.
When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?
1.
Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives
2.
Hypercoagulable State: Factors that Contribute to Blood Clots
3.
Treating Methemoglobinemia: What You Need to Know Now!
4.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
3.
Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.
4.
Navigating the Complexities of Ph Negative ALL - Part XIII
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation